HUBUNGAN KARAKTERISTIK DENGAN PERIODE RAWAT INAP PASIEN COVID-19 YANG MENDAPAT TERAPI FAVIPIRAVIR
Abstract
Background: Covid-19 is a disease caused by the SARS-CoV-2 (Server acute respiratory syndrome coronavirus 2) virus. The transmission of Covid-19 was so fast the on January 30, 2020 WHO declared Coronavirus as KKMD. The high number of cases of Covid-19 has resulted in a lack of capacity for health facilities, thus making inpatient medical services less than optimal and adequate. Objective: To determine the relationship between characteristics with the period of hospitalization of Covid-19 patients receiving favipiravir therapy at the Mitra Bangsa Hospital, Pati.
Methods: this type of analytic observational study with a retrospective approach, was conducted in May-June 2021 at Mitra Bangsa Hospital, Pati. Purposive sampling, and data collection using Covid-19 patient medical record. The number of sampels obtained was 59 respondents, and data analysis was carried out statistically using bivariat analysis with Chi Square test.
Results: the most gender was male 32 patients (54.2%), the most age 46-59 as many 29 patients (49.2%), then Covid-19 patients had the most comorbidities as many as 39 patients (67.8%) with the most common disiase was diabetes melitus with 19 patiens (32.2%). The result of the Chi Square test showed that there was a relationship between gender with lengts of stay p-value: 0.640, relationship between age with length of stay p-value: 0.806, and comorbid relationship with length of stay p-value: 0.301.
Conclusion: There is relationship between characteristics with the period of hospitalization of Covid-19 patients receiving favipiravir therapy at the Mitra Bangsa hospital Pati.
Keywords: Covid-19, Favipiravir, Hospitalization
Full Text:
PDFReferences
A, S. et al. (2022) ‘Hubungan Lama Rawat Inap dengan Usia dan Komorbiditas Pasien COVID-19 di Semen Padang Hospital dari Maret hingga Juli 2020’, Health and Medical Journal, 4(1), pp. 35–39. Available at: https://jurnal.unbrah.ac.id/index.php/heme/article/view/933.
Agrawal, U., Raju, R. and Udwadia, Z. F. (2020) ‘Favipiravir: A new and emerging antiviral option in COVID-19’, Medical Journal Armed Forces India, 76(4), pp. 370–376. doi: 10.1016/j.mjafi.2020.08.004.
Ariandra, A. (2021) ‘Covid-19: Epidemiologi, Virologi, Penularan, Gejala Klinis, Diagnsa, Tatalaksana, Faktor Resiko Dan Pencegahan’, jurnal Penelitian Perawat Profesional, 3(November), pp. 653–660. Available at: http://jurnal.globalhealthsciencegroup.com/index.php/JPPP/article/download/83/65.
Baihaqi, F. A. and Rumaropen, H. (2022) ‘Faktor-Faktor yang Berhubungan dengan Lama Rawat Inap Pasien COVID-19 di RSUD Serui Provinsi Papua: Studi Potong Lintang’, Jurnal Penyakit Dalam Indonesia, 8(4), p. 187. doi: 10.7454/jpdi.v8i4.627.
Diana, Z. (2021) ‘Hubungan antara Persepsi Risiko COVID-19 dan Self-Efficacy Menghadapi COVID-19 dengan Kepatuhan terhadap Protokol Kesehatan pada Masyarakat Surabaya The Relationship between COVID-19 Risk Perception and Self-Efficacy in Facing COVID-19 with Compliance wit’, Mind Set Edisi Khusus TIN, 1(1), pp. 105–116.
Eby Juliana Sabrima1, Riona Sanjaya, Surmiasih, Y. D. S. (2020) ‘Antiviral Therapy in Corona Virus Disease-19 (Covid-19) Laisa’, Biomedical Journal of Indonesia, 6(3), pp. 357–363.
Fahmia, R., Helda, H. and Nursari, A. Y. (2022) ‘Lama Rawat Inap Pasien Terkonfirmasi COVID-19 di Rumah Sakit Universitas Indonesia dan Faktor yang Mempengaruhinya.’, Jurnal Epidemiologi Kesehatan Indonesia, 6(1), pp. 1–12. doi: 10.7454/epidkes.v6i1.5004.
Illah, M. N. N. (2021) ‘Analisis Pengaruh Komorbid, Usia, Dan Jenis Kelamin Terhadap Meningkatnya Angka Kematian Pada Masa Pandemi Covid-19’, jurnal Sosial dan Sains, 1, pp. 1228–1233.
Kab.Pati (2021) Data Kasus Covid-19. Available at: https://covid19.patikab.go.id/v4/ (Accessed: 30 November 2021).
Keputusan Menteri Kesehatan Republik Indonesia (2020) ‘Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Corona Virus Disease 2019 (Covid-19)’, MenKes/413/2020, p. 207.
Larasati, L., Kusuma, W. A. and Annisa, A. (2020) ‘Model Prediksi Interaksi Senyawa dan Protein untuk Drug Repositioning menggunakan Deep Semi-Supervised Learning’, Jurnal Teknologi Informasi dan Ilmu Komputer, 7(4), p. 727. doi: 10.25126/jtiik.2020742236.
Levani, Prastya and Mawaddatunnadila (2021) ‘Coronavirus Disease 2019 (COVID-19): Patogenesis, Manifestasi Klinis dan Pilihan Terapi’, Jurnal Kedokteran dan Kesehatan, 17(1), pp. 44–57.
Lukito, J. I. (2020) ‘Tinjauan Antivirus untuk Terapi COVID-19’, 340 Cdk-286, 47(5), p. PP:342.
Novembrina, M. and Ati, A. A. (2021) ‘The effectively of favipiravir as antiviral therapy in the treatment of covid-19 in the several hospital in Blora, Indonesia’, Pharmacy & Pharmacology International Journal, 9(6), pp. 227–229. doi: 10.15406/ppij.2021.09.00349.
Putri, R. N. (2020) ‘Indonesia dalam Menghadapi Pandemi Covid-19’, Jurnal Ilmiah Universitas Batanghari Jambi, 20(2), p. 705. doi: 10.33087/jiubj.v20i2.1010.
Retno Wulandari, Safitri, A. and Sri Mintasih (2021) ‘Tingkat Kecemasan dengan Lama Rawat Inap Covid 19’, Journal of Nursing Education and Practice, 1(2), pp. 22–31. doi: 10.53801/jnep.v1i2.31.
Ruhama, R. S., Mahmudah, F. and Sastyarina, Y. (2021) ‘Karakteristik Pasien Terkonfirmasi Coronavirus disease (COVID-19) di RS X Samarinda Periode Maret-Desember 2020’, Proceeding of Mulawarman Pharmaceuticals Conferences, 14(December 2020), pp. 262–266. doi: 10.25026/mpc.v14i1.582.
SatgasCovid-19 (2021) Peta Sebaran Covid-19. Available at: https://covid19.go.id/peta-sebaran (Accessed: 30 November 2021).
Setiadi, A. P. et al. (2020) ‘Tata Laksana Terapi Pasien dengan COVID-19: Sebuah Kajian Naratif’, Indonesian Journal of Clinical Pharmacy, 9(1), pp. 70–94. doi: 10.15416/ijcp.2020.9.1.70.
Suryaputra, G. P., Apriningsih, H. and Wardani, M. M. (2022) ‘Hubungan Komorbid dengan Mortalitas dan Lama Rawat Inap pada Pasien COVID-19 di Rumah Sakit UNS Surakarta’, Plexus Medical Journal, 1(1), pp. 32–41. doi: 10.20961/plexus.v1i1.20.
Susilo, A. et al. (2020) ‘Coronavirus Disease 2019: Tinjauan Literatur Terkini’, Jurnal Penyakit Dalam Indonesia, 7(1), p. 45. doi: 10.7454/jpdi.v7i1.415.
DOI: https://doi.org/10.26751/ijf.v7i2.1753
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Indonesia Jurnal Farmasi
Published by Universitas Muhammadiyah Kudus
Jl. Ganesha Raya No.I, Purwosari, Kec. Kota Kudus, Kabupaten Kudus, Jawa Tengah 59316
IJF (Indonesia Jurnal Farmasi) indexed by
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.